Full Press Release Details
604 Page 1 of 2 15 July
Corporations Act 2001
Notice of change of interests of
| To Company Name/Scheme | Alterity Therapeutics Limited |
| ACN/ARSN | 080 699 065 |
| Name | The Bank of New York Mellon Corporation (BNYMC) and each Group Entity listed in Annexure A (Group Entity), (together BNYMC Group) | |
| ACN/ARSN (if applicable) |
| There was a change in the interests of the substantial holder on | 21 / May / 2025 | |
| The previous notice was given to the company on | 09 / May / 2025 | |
| The previous notice was dated | 08 / May / 2025 |
The total number of votes attached to all the voting shares in the
company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required,
and when now required, to give a substantial holding notice to the company or scheme, are as follows:
| Class of securities (4) | Previous notice | Present notice | ||
| Person's votes | Voting power (5) | Person's votes | Voting power (5) | |
| Ordinary shares | 2,373,752,074 | 26.01% | 2,466,998,317* | 27.03%* |
| *See Note 1 in Annexure C |
Particulars of each change in, or change in the nature of, a relevant
interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last
required to give a substantial holding notice to the company or scheme are as follows:
| Date of change | Person whose relevant interest changed | Nature of change (6) | Consideration given in relation to change (7) | Class and number of securities affected | Person's votes affected |
| See Annexure B |
Particulars of each relevant interest of the substantial
holder in voting securities after the change are as follows:
| Holder of relevant interest | Registered holder of securities | Person entitled to be registered as holder (8) | Nature of relevant interest (6) | Class and number of securities | Person's votes |
| See Annexure C |
604 Page 2 of 2 15 July
The persons who have become associates (2) of, ceased to be associates
of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or
scheme are as follows:
| Name and ACN/ARSN (if applicable) | Nature of association |
| BNYMC and each Group Entity | Each Group Entity is an associate of BNYMC pursuant to section 12(2)(a) of the Corporations Act 2001 (Cth) as each entity is directly or indirectly owned and controlled by BNYMC. |
The addresses of persons named in this form are as follows:
| Name | Address |
| The Bank of New York Mellon Corporation | 240 Greenwich Street, New York, NY 10286 USA |
| Each Group Entity | 240 Greenwich Street, New York, NY 10286 USA |
| print name | Andrew Weiser | capacity | Attorney-In-Fact | |
| sign here | /s/ Andrew Weiser | date | 22 / May / 2025 |
is Annexure A of 1 page referred to in Form 604 Notice of Change
of Interests of Substantial Holder given by The Bank of New York
Corporation and its related bodies corporate.
The Bank of New York Mellon Corporation
is the ultimate parent company of a corporate group comprised of a large number of operating and holding companies. Details of the entities
directly owned and controlled by The Bank of New York Mellon Corporation are listed below.
| print name | Andrew Weiser | capacity | Attorney-In-Fact | |
| Sign here | /s/ Andrew Weiser | date | 22/May/2025 |
This is Annexure B of 1 page referred to in Form 604 Notice of Change
of Interests of Substantial Holder given by The Bank of New York Mellon Corporation and its related bodies corporate
Changes in relevant interests
| Date of change | Person whose relevant interest changed | Nature of Change | Consideration given in relation to change | Class and number of securities affected (Ordinary Shares) | Person's votes affected |
| 9-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 9,000,000 | 9,000,000 |
| 12-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 30,000,000 | 30,000,000 |
| 12-May-2025 | The Bank of New York Mellon | Transfer Out of securities | N/A | (15,000,000) | (15,000,000) |
| 12-May-2025 | Pershing LLC | Transfer In of securities | N/A | 0.4042 ADRs (Converted = 243 Ord) | 243 |
| 13-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 960,000 | 960,000 |
| 14-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 33,900,000 | 33,900,000 |
| 15-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 16,800,000 | 16,800,000 |
| 19-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 12,000,000 | 12,000,000 |
| 20-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 486,000 | 486,000 |
| 21-May-2025 | The Bank of New York Mellon | Deposit of securities | N/A | 5,100,000 | 5,100,000 |
| Print Name - | Andrew Weiser | Capacity - | Attorney-In-Fact | |
| Sign Here | /s/ Andrew Weiser | Date - | 22 May 2025 |
is Annexure C of 2 pages referred to in Form 604 Notice of
Change of Interests of Substantial Holder given by The Bank of New
Corporation and its related bodies corporate
| Holder of relevant interest | Nature of relevant interest | Class and number of securities |
| The Bank of New York Mellon ( BNYM ) | Remote Interest Held Under Deposit Agreement Relevant interest under section 608(1)(c) of the Corporations Act 2001 (Cth) arising from BNYM having the limited power to dispose of, or control the exercise of a power to dispose of, securities deposited with or held by BNYM (or its custodian or agent) in its capacity as depositary administering an ADR program for Alterity Therapeutics Limited (Company) under the Deposit Agreement dated January 2, 2008 between the Company, holders of American depositary receipts (ADRs) and BNYM (Deposit Agreement). [*See Note 1 below]. | 2,466,997,348 ordinary shares |
| BNYMC Group (other than BNYM) | Relevant interest under section 608(3)(a) and/or section 608(3)(b) of the Corporations Act 2001 (Cth) being a relevant interest held through a body corporate (namely BNYM) in which the voting power of each other entity in the BNYMC Group is above 20%, or that each other entity in the BNYMC Group controls. [*See Note 1 and Note 2 below] | 2,466,997,348 ordinary shares |
| Pershing LLC | Relevant interest under sections 608(1) of the Corporations Act 2001 (Cth) arising from Pershing LLC being the registered owner of the securities. | 969 ordinary shares |
| BNYMC Group (other than Pershing LLC) | Relevant interest under section 608(3)(a) and/or section 608(3)(b) of the Corporations Act 2001 (Cth) being a relevant interest held through a body corporate (namely Pershing LLC) in which the voting power of each other entity in the BNYMC Group is above 20%, or that each other entity in the BNYMC Group controls. [*See Note 2 below] | 969 ordinary shares |
| Print Name - | Andrew Weiser | Capacity - | Attorney-In-Fact | |
| Sign Here | /s/ Andrew Weiser | Date - | 22/May/2025 |